Nuclear Receptors in Nonalcoholic Fatty Liver Disease

被引:31
作者
Lopez-Velazquez, Jorge A. [1 ]
Carrillo-Cordova, Luis D. [1 ]
Chavez-Tapia, Norberto C. [1 ]
Uribe, Misael [1 ]
Mendez-Sanchez, Nahum [1 ]
机构
[1] Medica Clin & Fdn, Liver Res Unit, Puente Piedra 150,Colonia Toriello Guerra, Mexico City 14050, DF, Mexico
关键词
D O I
10.1155/2012/139875
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Nuclear receptors comprise a superfamily of ligand-activated transcription factors that are involved in important aspects of hepatic physiology and pathophysiology. There are about 48 nuclear receptors in the human. These nuclear receptors are regulators of many hepatic processes including hepatic lipid and glucose metabolism, bile acid homeostasis, drug detoxification, inflammation, regeneration, fibrosis, and tumor formation. Some of these receptors are sensitive to the levels of molecules that control lipid metabolism including fatty acids, oxysterols, and lipophilic molecules. These receptors direct such molecules to the transcriptional networks and may play roles in the pathogenesis and treatment of nonalcoholic fatty liver disease. Understanding the mechanisms underlying the involvement of nuclear receptors in the pathogenesis of nonalcoholic fatty liver disease may offer targets for the development of new treatments for this liver disease.
引用
收藏
页数:10
相关论文
共 94 条
[1]
Overproduction of large VLDL particles is driven by increased liver fat content in man [J].
Adiels, M ;
Taskinen, MR ;
Packard, C ;
Caslake, MJ ;
Soro-Paavonen, A ;
Westerbacka, J ;
Vehkavaara, S ;
Hakkinen, A ;
Olofsson, SO ;
Yki-Jarvinen, H ;
Borén, J .
DIABETOLOGIA, 2006, 49 (04) :755-765
[2]
Nuclear Receptors, Inflammation, and Liver Disease: Insights for Cholestatic and Fatty Liver Diseases [J].
Arrese, M. ;
Karpen, S. J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (04) :473-478
[3]
Auwerx J, 1999, CELL, V97, P161
[4]
PPARδ:: a dagger in the heart of the metabolic syndrome [J].
Barish, GD ;
Narkar, VA ;
Evans, RM .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (03) :590-597
[5]
TRANSCRIPTIONAL CONTROL BY NUCLEAR RECEPTORS [J].
BEATO, M .
FASEB JOURNAL, 1991, 5 (07) :2044-2051
[6]
PPARs: therapeutic targets for metabolic disease [J].
Berger, JP ;
Akiyama, TE ;
Meinke, PT .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (05) :244-251
[7]
The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice [J].
Cariou, B ;
van Harmelen, K ;
Duran-Sandoval, D ;
van Dijk, TH ;
Grefhorst, A ;
Abdelkarim, M ;
Caron, S ;
Torpier, G ;
Fruchart, JC ;
Gonzalez, FJ ;
Kuipers, F ;
Staels, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (16) :11039-11049
[8]
Nuclear receptors in macrophage biology: At the crossroads of lipid metabolism and inflammation [J].
Castrillo, A ;
Tontonoz, P .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2004, 20 :455-480
[9]
The liver X receptor (LXR) and hepatic lipogenesis - The carbohydrate-response element-binding protein is a target gene of LXR [J].
Cha, Ji-Young ;
Repa, Joyce J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (01) :743-751
[10]
Role of nonalcoholic fatty liver disease in hepatocellular carcinoma [J].
Chavez-Tapia, Norberto C. ;
Mendez-Sanchez, Nahum ;
Uribe, Misael .
ANNALS OF HEPATOLOGY, 2009, 8 :S34-S39